RAYDIAX
PrivateLast Round
Grant
Mar 4, 2026
Total Funding Raised
$6.6M
Momentum Score
25 /100
Company Overview
RAYDIAX is a medical technology company that develops a therapy-assistance computed tomography (CT) system for minimally invasive cancer interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Precision Medicine, Computing Hardware
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RAYDIAX Comps
Public and private peers based on sector, stage, and business model.
RAYDIAX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 4, 2026 | ||||
| Grant | Oct 26, 2023 | ||||
| Seed | Oct 26, 2023 |
Key People
Founding team and executive leadership
RAYDIAX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| IBG Risikokapitalfonds Sachsen-Anhalt | Seed, Grant |
| Federal Ministry for Economic Affairs and Energy | Grant |
| GETEC Family Office | Grant |
| Bmp Ventures | Grant, Seed |
| High-Tech Gründerfonds | Seed |
RAYDIAX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RAYDIAX's valuation, stock price, and market status.
